---
title: "Weixing: Net profit in the third quarter was 214 million yuan, a year-on-year increase of 3.03%"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/263064495.md"
description: "Weixing announced that the revenue for the third quarter was 1.295 billion yuan, a year-on-year increase of 0.86%; the net profit was 214 million yuan, a year-on-year increase of 3.03%. The revenue for the first three quarters was 3.633 billion yuan, a year-on-year increase of 1.46%; the net profit was 583 million yuan, a year-on-year decrease of 6.46%"
datetime: "2025-10-28T10:58:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263064495.md)
  - [en](https://longbridge.com/en/news/263064495.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263064495.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/263064495.md) | [English](https://longbridge.com/en/news/263064495.md)


# Weixing: Net profit in the third quarter was 214 million yuan, a year-on-year increase of 3.03%

Weixing announced that its revenue for the third quarter was 1.295 billion yuan, a year-on-year increase of 0.86%; net profit was 214 million yuan, a year-on-year increase of 3.03%. Revenue for the first three quarters was 3.633 billion yuan, a year-on-year increase of 1.46%; net profit was 583 million yuan, a year-on-year decrease of 6.46%

### 相關股票

- [Weixing (002003.CN)](https://longbridge.com/zh-HK/quote/002003.CN.md)

## 相關資訊與研究

- [Taiwan February exports +20.6% y/y, below forecasts](https://longbridge.com/zh-HK/news/278353139.md)
- [BYD weighs Canada plant, legacy automaker buyout amid global push](https://longbridge.com/zh-HK/news/278974771.md)
- [Fosun Pharma Unit Gets China Nod for Hematological Malignancy Drug Trial](https://longbridge.com/zh-HK/news/279052280.md)
- [Xprize founder Peter Diamandis launches new contest to manifest a new Star Trek](https://longbridge.com/zh-HK/news/278419951.md)
- [12:04 ETdancemoon JustHang Squeegee -- GIA Finalist for The Inspired Home Show 2026](https://longbridge.com/zh-HK/news/278751759.md)